Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial

被引：0
作者：
Matthias Uhl
Klaus Herfarth
Michael J Eble
Michael Pinkawa
Baukelien van Triest
Robin Kalisvaart
Damien C Weber
Raymond Miralbell
Danny Y Song
Theodore L DeWeese
机构：
[1] University of Heidelberg,Department of Radiation Oncology
[2] RWTH Aachen University,Department of Radiation Oncology
[3] NKI-AVL Nederlands Kanker Instituut - Antoni van Leeuwenhoek,Department of Radiation Oncology
[4] Geneva University Hospital,Department of Radiation Oncology
[5] Johns Hopkins University School of Medicine,Department of Radiation Oncology and Molecular Radiation Sciences
来源：
Radiation Oncology | / 9卷
关键词：
Prostate cancer; Radiotherapy; Rectal toxicity; Hydrogel; Spacer; IMRT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Improving prostate brachytherapy quality assurance with MRI-CT fusion based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer
    Brown, Aaron P.
    Pugh, Thomas J.
    Swanson, David A.
    Kudchadker, Rajat J.
    Bruno, Teresa L.
    Christensen, Eva N.
    van Vulpen, Marco
    Frank, Steven J.
    BRACHYTHERAPY, 2013, 12 (05) : 401 - 407
  • [42] Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial
    Palussiere, J.
    Chomy, F.
    Savina, M.
    Deschamps, F.
    Gaubert, J. Y.
    Renault, A.
    Bonnefoy, O.
    Laurent, F.
    Meunier, C.
    Bellera, C.
    Mathoulin-Pelissier, S.
    de Baere, T.
    JOURNAL OF CARDIOTHORACIC SURGERY, 2018, 13
  • [43] Stereotactic focal radiotherapy as an alternative treatment for low-risk prostate cancer: Results of a single-arm monocenter Phase-II trial
    Nguyen, Paul V.
    Donneaux, Bertrand
    Louis, Celine
    Bodgal, Zsuzsa
    Philippi, Sven
    Biver, Sylvie
    Frederick, Berangere
    Harze, Ludovic
    Lasar, Yves
    Vogin, Guillaume
    Nickers, Philippe
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)
    Armstrong, Wesley R.
    Kishan, Amar U.
    Booker, Kiara M.
    Grogan, Tristan R.
    Elashoff, David
    Lam, Ethan C.
    Clark, Kevyn J.
    Steinberg, Michael L.
    Fendler, Wolfgang P.
    Hope, Thomas A.
    Nickols, Nicholas G.
    Czernin, Johannes
    Calais, Jeremie
    EUROPEAN UROLOGY, 2024, 86 (01) : 52 - 60
  • [45] LONG-TERM RESULTS OF A PROSPECTIVE, PHASE II STUDY OF LONG-TERM ANDROGEN ABLATION, PELVIC RADIOTHERAPY, BRACHYTHERAPY BOOST, AND ADJUVANT DOCETAXEL IN PATIENTS WITH HIGH-RISK PROSTATE CANCER
    DiBiase, Steven J.
    Hussain, Arif
    Kataria, Ritesh
    Amin, Pradip
    Bassi, Sunakshi
    Dawson, Nancy
    Kwok, Young
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03): : 732 - 736
  • [46] Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial
    Welsh, James W.
    Seyedin, Steven N.
    Allen, Pamela K.
    Hofstetter, Wayne L.
    Ajani, Jaffer A.
    Chang, Joe Y.
    Gomez, Daniel R.
    Amini, Arya
    Swisher, Stephen G.
    Blum, Mariela A.
    Younes, Ahmed I.
    Quynh-Nhu Nguyen
    Minsky, Bruce D.
    Erasmus, Jeremy J.
    Lee, Jeffrey H.
    Bhutani, Manoop
    Komaki, Ritsuko U.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 375 - 382
  • [47] Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial
    Ahlgren, Goran M.
    Flodgren, Per
    Tammela, Teuvo L. J.
    Kellokumpu-Lehtinen, Pirkko
    Borre, Michael
    Angelsen, Anders
    Iversen, Jon Reidar
    Sverrisdottir, Asgerdur
    Jonsson, Eirikur
    Sengelov, Lisa
    EUROPEAN UROLOGY, 2018, 73 (06) : 870 - 876
  • [48] Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity:: Results of a prospective multicenter study of 166 patients
    Goldner, Gregor
    Tomicek, Birgit
    Becker, Gerd
    Geinitz, Hans
    Wachter, Stefan
    Zimmermann, Frank
    Wachter-Gerstner, Natascha
    Reibenwein, Jochen
    Glocker, Stefan
    Bamberg, Michael
    Feldmann, Horst
    Poetzi, Regina
    Molls, Michael
    Poetter, Rochard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 78 - 83
  • [49] OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer
    Supiot, Stephane
    Vaugier, Loig
    Pasquier, David
    Buthaud, Xavier
    Magne, Nicolas
    Peiffert, Didier
    Sargos, Paul
    Crehange, Gilles
    Pommier, Pascal
    Loos, Genevieve
    Hasbini, Ali
    Latorzeff, Igor
    Silva, Marlon
    Denis, Fabrice
    Lagrange, Jean-Leon
    Morvan, Cyrille
    Campion, Loic
    Blanc-Lapierre, Audrey
    EUROPEAN UROLOGY, 2021, 80 (04) : 405 - 414
  • [50] Efficacy and Safety of Tadalafil 20 mg on Demand vs. Tadalafil 5 mg Once-a-Day in the Treatment of Post-Radiotherapy Erectile Dysfunction in Prostate Cancer Men: A Randomized Phase II Trial
    Ricardi, Umberto
    Gontero, Paolo
    Ciammella, Patrizia
    Badellino, Serena
    Valentino, Franco
    Munoz, Fernando
    Guarneri, Alessia
    Rondi, Nadia
    Moretto, Francesco
    Filippi, Andrea Riccardo
    Ragona, Riccardo
    Tizzani, Alessandro
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 (08) : 2851 - 2859
12345